We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 23 JANUARY 2016
Lee Pharma's Compulsory License Application For Saxagliptin Rejected By Indian Patent Office

Khaitan & Co.
Contributor

Khaitan & Co.
Founded in 1911, Khaitan & Co is a heritage law firm that has been a trusted adviser to leading...
View firm profileIn an order dated 19 January 2016 (Order), the Controller General of Patents and Trademarks rejected the application for Compulsory License for the patent covering AstraZeneca's diabetes management drug Saxagliptin.
IndiaIntellectual Property









